Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Drug Information » FDA Approved Drugs » 1997
Medical Areas: Nephrology | Family Medicine | Urology

View By:YearCompanyConditionsTherapeutic AreasDrug Names

FLOMAX

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Boehringer Ingelheim
Approval Status: Approved October 1997
Treatment Area: benign prostatic hypertrophy (BPH)

General Information

FLOMAX has been approved for the treatment of benign prostatic hypertrophy (BPH). Boehringer Ingelheim, which licensed the product from originator Yamanouchi, will market the product in the U.S.